SCHEMBL7147015

SCHEMBL7147015

c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.59
CHEK1 O14757 11/20 0.56
BACE1 P56817 2/20 0.56
LTA4H P09960 1/20 0.54
MAP4K4 O95819 2/20 0.53
MELK Q14680 2/20 0.53
GAK O14976 1/20 0.53
DYRK3 O43781 1/20 0.53
JAK2 O60674 1/20 0.53
PRKD3 O94806 1/20 0.53
NQO2 P16083 1/20 0.53
CSNK2A2 P19784 1/20 0.53
FECH P22830 1/20 0.53
JAK1 P23458 1/20 0.53
TYK2 P29597 1/20 0.53
MAPK8 P45983 1/20 0.53
MAPK9 P45984 1/20 0.53
CSNK1A1 P48729 1/20 0.53
CSNK1D P48730 1/20 0.53
CSNK1E P49674 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703663 0.95 CHEK1 (0.62) KDRCHEK1BACE1MELKRET
SCHEMBL7140591 0.93 KDR (0.64) KDRCHEK1BACE1LTA4HMAP4K4
SCHEMBL7147004 0.93 KDR (0.68) KDRCHEK1MAP4K4MELKRET
SCHEMBL7703072 0.92 KDR (0.55) KDRCHEK1BACE1LTA4HMAP4K4
SCHEMBL7172093 0.91 KDR (0.58) KDRCHEK1LTA4HMAP4K4MELK
SCHEMBL7699601 0.90 CHEK1 (0.62) KDRCHEK1MAP4K4MELKRET
SCHEMBL7702402 0.89 KDR (0.63) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7700924 0.88 KDR (0.67) KDRCHEK1MELKRETMARK3
SCHEMBL7702307 0.87 KDR (0.54) KDRCHEK1MELKRETMARK3
SCHEMBL7702517 0.87 KDR (0.57) KDRCHEK1MAP4K4MELKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed